Other
Domain Therapeutics
is a France-based biopharmaceutical company that researches and develops GPCR-mediated immunotherapies for the treatment of cancer... Read moreDomain Therapeutics
is a France-based biopharmaceutical company that researches and develops GPCR-mediated immunotherapies for the treatment of cancer... Read moreNews
Jan 13, 2026
Pharmabiz
Domain Therapeutics: Domain Therapeutics becomes Kainova Therapeutics and advances its clinical pipeline of GPCRmodulating therapies
Nov 13, 2025
PR-Inside
Press Release: Domain Therapeutics : Philadelphia Corporation for Aging Data Breach - Levi & Korsinsky, ...
Oct 28, 2025
PharmaTimes
Domain Therapeutics: Domain Therapeutics begins patient dosing in phase 1/2 trial of DT-7012
Apr 30, 2025
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025
Apr 01, 2025
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics to Present Data on its GPCR Lead Programs at AACR Annual Meeting 2025
Mar 20, 2025
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics Discloses DT-9046 as a Groundbreaking Oral Drug Candidate for Inflammatory Diseases
Jun 06, 2024
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics Strengthens Its Intellectual Property for Its Series of Treg Depleting anti-CCR8 Antibodies, Including Best-in-class Candidate DT-7012
Apr 08, 2024
FinanzNachrichten
Domain Therapeutics: Domain Therapeutics to Participate at Premier Investor and Healthcare Conferences
Mar 26, 2024
Business Wire
Domain Therapeutics: Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology, at AACR 2024 Annual Meeting, Highlighting Clear Competitive Advantages of This Candidate
Mar 12, 2024
Contract Pharma
Domain Therapeutics: Domain Therapeutics & Chime Biologics Sign Manufacturing Service Agreement
